Like Glenmark Pharma, Sun Pharma: Deven Choksey

Deven Choksey of KRChoksey Investment Managers told CNBC-TV18, "We continue to like names like Glenmark Pharma and the Sun Pharmaceutical Industries for the simple reason that we see the visibility of earnings of those companies under different propositions. So, certainly I think those are the two companies we continue to like them in the portfolio.""Overall we find that these two companies offer you better visibility from a product launch which is better in the form of revenues and better visibility in form of pipeline of the products as I would like to call it," he said.